Retatrutide heeft geen goedkeuring van de EMA of het Nederlandse CBG-MEB, wat betekent dat het niet als geneesmiddel verkrijgbaar is in Nederland
To view or add a comment, sign in Chronic neuropathic pain is a major cause of disability globally, and its impact is expected to grow
Outcome measures cover histological damage scoring, cytokine panels (TNF-, IL-6, IL-10), mucosal blood flow, tight junction protein expression by Western blot, and stool consistency scoring for colitis models
Article 10 mins 5 Ways to Position Risk Capital as a Value Driver In today's uncertain economic climate, finance leaders must innovate beyond traditional financial metrics, managing risk capital through targeted risk strategies, holistic capital approaches and proactive stances toward emerging threats